95 related articles for article (PubMed ID: 2046680)
21. A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?
Petkov PI; Patlewicz G; Schultz TW; Honma M; Todorov M; Kotov S; Dimitrov SD; Donner EM; Mekenyan OG
Regul Toxicol Pharmacol; 2015 Jun; 72(1):17-25. PubMed ID: 25792138
[TBL] [Abstract][Full Text] [Related]
22. The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity.
Buist H; Aldenberg T; Batke M; Escher S; Klein Entink R; Kühne R; Marquart H; Pauné E; Rorije E; Schüürmann G; Kroese D
Regul Toxicol Pharmacol; 2013 Nov; 67(2):170-81. PubMed ID: 23357514
[TBL] [Abstract][Full Text] [Related]
23. An integrative test strategy for cancer hazard identification.
Luijten M; Olthof ED; Hakkert BC; Rorije E; van der Laan JW; Woutersen RA; van Benthem J
Crit Rev Toxicol; 2016 Aug; 46(7):615-39. PubMed ID: 27142259
[TBL] [Abstract][Full Text] [Related]
24. [Genotoxic and clastogenic effects of doxorubicin].
Villani P; Orsière T; Duffaud F; Digue L; Bouvenot G; Botta A
Therapie; 1998; 53(4):391-5. PubMed ID: 9806010
[TBL] [Abstract][Full Text] [Related]
25. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals.
Gold LS; Slone TH; Stern BR; Bernstein L
Mutat Res; 1993 Mar; 286(1):75-100. PubMed ID: 7678909
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of non-genotoxic carcinogenesis.
Shaw IC; Jones HB
Trends Pharmacol Sci; 1994 Mar; 15(3):89-93. PubMed ID: 8184492
[TBL] [Abstract][Full Text] [Related]
27. A structural analysis of the genotoxic and carcinogenic potentials of cyclosporin A.
Rosenkranz HS; Klopman G
Mutagenesis; 1992 Mar; 7(2):115-8. PubMed ID: 1579066
[TBL] [Abstract][Full Text] [Related]
28. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
29. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
[TBL] [Abstract][Full Text] [Related]
30. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 17. Can a mechanistic rationale be provided for non-genotoxic carcinogens identified in rodent bioassays?
Clayson DB
Mutat Res; 1989 Jul; 221(1):53-67. PubMed ID: 2664495
[TBL] [Abstract][Full Text] [Related]
31. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches.
Benigni R
Chem Rev; 2005 May; 105(5):1767-800. PubMed ID: 15884789
[No Abstract] [Full Text] [Related]
33. Genotoxicity and carcinogenicity of metronidazole.
Dobiás L; Cerná M; Rössner P; Srám R
Mutat Res; 1994 Jun; 317(3):177-94. PubMed ID: 7515153
[No Abstract] [Full Text] [Related]
34. [Characteristics of genotoxic and carcinogenic action of metals].
Maksimchuk TP; Babenko GA
Eksp Onkol; 1990; 12(4):3-9. PubMed ID: 2199186
[TBL] [Abstract][Full Text] [Related]
35. Mutagens that are not carcinogens: faulty theory or faulty tests?
Zeiger E
Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic events during the process of cell transformation induced by carcinogens (review).
Nguyen-Ba G; Vasseur P
Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
[TBL] [Abstract][Full Text] [Related]
37. Genotoxicty and mutagenicity.
Maurici D; Aardema M; Corvi R; Kleber M; Krul C; Laurent C; Loprieno N; Pasanen M; Pfuhler S; Phillips B; Sabbioni E; Sanner T; Vanparys P
Altern Lab Anim; 2005 Jul; 33 Suppl 1():117-30. PubMed ID: 16194145
[No Abstract] [Full Text] [Related]
38. Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
Silva Lima B; Van der Laan JW
Regul Toxicol Pharmacol; 2000 Oct; 32(2):135-43. PubMed ID: 11067770
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic relationship among mutagenicity, skin sensitization, and skin carcinogenicity.
Ashby J; Hilton J; Dearman RJ; Callander RD; Kimber I
Environ Health Perspect; 1993 Apr; 101(1):62-7. PubMed ID: 8513766
[TBL] [Abstract][Full Text] [Related]
40. Non-genotoxic carcinogens. Approaches to their risk assessment.
Castro JA; Díaz Gómez MI; Castro GD
Biomed Environ Sci; 1993 Mar; 6(1):71-80. PubMed ID: 8476535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
